Disruption of caveolae or caveolin-3 expression in DM [135, 250–253] is thus predicted to limit cardiac InsR signaling, although a parallel elevation in caveolin-1 as reported in a rat T1DM model [252] may modulate such effects. The gene discussed is CAV3; the disease is diabetes mellitus.